Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

DNAH14 Inhibitors

DNAH14 inhibitors belong to a distinctive chemical class that exhibits a specialized mechanism of action aimed at modulating cellular processes. DNAH14, a prominent member of the dynein axonemal heavy chain family, plays a pivotal role in the intricate architecture and dynamic function of cilia and flagella, which are microtubule-based structures found on the surfaces of various eukaryotic cells. These cilia and flagella are vital for an array of functions, including cellular motility, sensory perception, and fluid movement. DNAH14 inhibitors are characterized by their ability to selectively interact with the DNAH14 protein, altering its function in a controlled manner. At a molecular level, these inhibitors are designed to bind to specific domains within the DNAH14 protein, thereby disrupting its normal conformation and affecting its biochemical activity. Particularly, these inhibitors often target the ATPase activity of DNAH14, an essential enzymatic function that fuels the ATP-dependent movement of cilia and flagella.

By interfering with this energy-transducing process, DNAH14 inhibitors can perturb the coordinated beating or waving motion of cilia and flagella, leading to functional impairment. The specificity of DNAH14 inhibitors for their target protein ensures a targeted approach in modulating cellular processes that heavily rely on intact ciliary and flagellar function. By perturbing the normal activity of DNAH14, researchers can gain valuable insights into the intricate interplay between these microtubule-based structures and the cellular contexts in which they operate. Additionally, the use of DNAH14 inhibitors enables scientists to investigate the consequences of impaired ciliary and flagellar function on cellular physiology, ultimately contributing to a more comprehensive understanding of cell biology and potential implications for various cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Imatinib mesylate

220127-57-1sc-202180
sc-202180A
25 mg
100 mg
$45.00
$111.00
61
(1)

A tyrosine kinase inhibitor studied in the research of certain types of leukemia and other cancers.

MDV3100

915087-33-1sc-364354
sc-364354A
5 mg
50 mg
$245.00
$1051.00
7
(1)

An androgen receptor inhibitor.

Ibrutinib

936563-96-1sc-483194
10 mg
$156.00
5
(0)

A Bruton's tyrosine kinase inhibitor studied in the research of B-cell malignancies such as chronic lymphocytic leukemia and mantle cell lymphoma.

Gefitinib

184475-35-2sc-202166
sc-202166A
sc-202166B
sc-202166C
100 mg
250 mg
1 g
5 g
$63.00
$114.00
$218.00
$349.00
74
(2)

An EGFR tyrosine kinase inhibitor used in the research of non-small cell lung cancer.

Rucaparib

283173-50-2sc-507419
5 mg
$150.00
(0)

An inhibitor of poly ADP ribose polymerase (PARP), studied in the research of ovarian cancer.

ABT-199

1257044-40-8sc-472284
sc-472284A
sc-472284B
sc-472284C
sc-472284D
1 mg
5 mg
10 mg
100 mg
3 g
$118.00
$337.00
$520.00
$832.00
$1632.00
10
(0)

A BCL-2 inhibitor used in the research of chronic lymphocytic leukemia and acute myeloid leukemia.